Order Article Reprints

Nardotto GHB, Svenson EM, Bollela VR, Rocha A, Slavov SN, Ximenez JPB, Della Pasqua O, Lanchote VL. Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter? Pharmaceutics. 2024; 16(8):970. https://doi.org/10.3390/pharmaceutics16080970

Nardotto, Glauco Henrique Balthazar, Elin M. Svenson, Valdes Roberto Bollela, Adriana Rocha, Svetoslav Nanev Slavov, João Paulo Bianchi Ximenez, Oscar Della Pasqua, and Vera Lucia Lanchote. 2024. "Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?" Pharmaceutics 16, no. 8: 970. https://doi.org/10.3390/pharmaceutics16080970

Nardotto, G. H. B., Svenson, E. M., Bollela, V. R., Rocha, A., Slavov, S. N., Ximenez, J. P. B., Della Pasqua, O., & Lanchote, V. L. (2024). Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter? Pharmaceutics, 16(8), 970. https://doi.org/10.3390/pharmaceutics16080970